Healthcare Technology Featured Article

August 26, 2014

European Medical Centers Using Multi-Modality Breast Imaging for Accurate Cancer Detection

Breast cancer is a very real threat for women everywhere, and even some men in rare cases. Early detection and treatment are key to stopping the cancer before it becomes a problem, and for most women this translates directly into regular mammograms. However, there are more options than just mammograms available for cancer detection with today's technology. In fact, European medical centers are currently using several different techniques to detect breast cancer in conjunction with one another. Not only is this leading to increased detection rates and decreased false positives, but it is also leading to increased market revenues for the multi-modality breast imaging system market in general.

In addition to mammography, European medical centers are employing a wide variety of breast imaging techniques including breast ultrasound, breast magnetic resonance imaging (MRI), molecular breast imaging (MBI) and even breast computer-aided detection (CAD). This combination of systems has led to $988.3 million in revenue for the European breast imaging systems market in 2013. According to an analysis from Frost & Sullivan, the total revenue is expected to reach over $1,384 million in 2020.

“The European market will continue to evolve as breast imaging systems vendors look for innovative technologies to battle the increasing rate of false positives and overcome limitations while scanning women with dense breast tissue,” claims Raghuraman Madanagopal, one of Frost & Sullivan's Healthcare Research Analysts. “3-D tomosynthesis, automated breast ultrasound and MBI are the results of such technological innovations that ensure maximum efficiency and minimum error rates.”

One of the major advantages European medical centers are finding from using multiple detection methods is a major reduction in false positives, as a second or third scan of a different type can confirm if an anomaly is actually cancerous.

Edited by Maurice Nagle

FREE eNewsletter

Click here to receive your targeted Healthcare Technology Community eNewsletter.
[Subscribe Now]